GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (LTS:0REN) » Definitions » Float Percentage Of Total Shares Outstanding

Edwards Lifesciences (LTS:0REN) Float Percentage Of Total Shares Outstanding : 99.14% (As of Jun. 01, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Edwards Lifesciences Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Edwards Lifesciences's float shares is 597.45 Mil. Edwards Lifesciences's total shares outstanding is 602.60 Mil. Edwards Lifesciences's float percentage of total shares outstanding is 99.14%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Edwards Lifesciences's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Edwards Lifesciences's Institutional Ownership is 53.11%.


Edwards Lifesciences Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Edwards Lifesciences's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=597.45/602.60
=99.14%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Edwards Lifesciences (LTS:0REN) Business Description

Address
One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

Edwards Lifesciences (LTS:0REN) Headlines

No Headlines